+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Wearable Injector Market by Type (Body Worn Patch Injector, Off Body Worn Patch Injector), Application (Autoimmune Disease, Cardiovascular Disease, Diabetes), End-Use - Forecast 2024-2030

  • PDF Icon

    Report

  • 194 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4989995
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Wearable Injector Market size was estimated at USD 7.84 billion in 2023, USD 8.71 billion in 2024, and is expected to grow at a CAGR of 11.26% to reach USD 16.56 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Wearable Injector Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Wearable Injector Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Wearable Injector Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., BASF SE, Becton, Dickinson and Company, DCA Design International Ltd, E3D Elcam Drug Delivery Devices, Gerresheimer AG, Insulet Corporation, Johnson & Johnson Service Co., Inc., Medtronic PLC, Neuma LLC, SCHOTT AG, SONCEBOZ SA, Stevanato Group S.p.A., Valeritas, Inc., and West Pharmaceutical Services, Inc.

Market Segmentation & Coverage

This research report categorizes the Wearable Injector Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Body Worn Patch Injector
    • Off Body Worn Patch Injector
  • Application
    • Autoimmune Disease
    • Cardiovascular Disease
    • Diabetes
    • Infectious Disease
    • Oncology
  • End-Use
    • Clinic
    • Home Care Setting
    • Hospital
    • Online Pharmacy
    • Retail Pharmacy
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Wearable Injector Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Wearable Injector Market?
  3. What are the technology trends and regulatory frameworks in the Wearable Injector Market?
  4. What is the market share of the leading vendors in the Wearable Injector Market?
  5. Which modes and strategic moves are suitable for entering the Wearable Injector Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Wearable Injector Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases and high demand for advanced drug delivery device
5.1.1.2. Rising demand for minimal invasive treatments
5.1.1.3. Need for subcutaneous and continuous drug delivery
5.1.2. Restraints
5.1.2.1. Low adoption in emerging economies
5.1.3. Opportunities
5.1.3.1. Increasing demand for biologics and mAbs
5.1.3.2. Advancement in injector technology
5.1.4. Challenges
5.1.4.1. Preference for alternative drug delivery modes
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Wearable Injector Market, by Type
6.1. Introduction
6.2. Body Worn Patch Injector
6.3. Off Body Worn Patch Injector
7. Wearable Injector Market, by Application
7.1. Introduction
7.2. Autoimmune Disease
7.3. Cardiovascular Disease
7.4. Diabetes
7.5. Infectious Disease
7.6. Oncology
8. Wearable Injector Market, by End-Use
8.1. Introduction
8.2. Clinic
8.3. Home Care Setting
8.4. Hospital
8.5. Online Pharmacy
8.6. Retail Pharmacy
8.7. Specialty Clinics
9. Americas Wearable Injector Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Wearable Injector Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Wearable Injector Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Amgen Inc.
13.1.2. BASF SE
13.1.3. Becton, Dickinson and Company
13.1.4. DCA Design International Ltd
13.1.5. E3D Elcam Drug Delivery Devices
13.1.6. Gerresheimer AG
13.1.7. Insulet Corporation
13.1.8. Johnson & Johnson Service Co., Inc.
13.1.9. Medtronic PLC
13.1.10. Neuma LLC
13.1.11. SCHOTT AG
13.1.12. SONCEBOZ SA
13.1.13. Stevanato Group S.p.A.
13.1.14. Valeritas, Inc.
13.1.15. West Pharmaceutical Services, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. WEARABLE INJECTOR MARKET RESEARCH PROCESS
FIGURE 2. WEARABLE INJECTOR MARKET SIZE, 2023 VS 2030
FIGURE 3. WEARABLE INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. WEARABLE INJECTOR MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. WEARABLE INJECTOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. WEARABLE INJECTOR MARKET DYNAMICS
FIGURE 7. WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 12. WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. WEARABLE INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. WEARABLE INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. WEARABLE INJECTOR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. WEARABLE INJECTOR MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL WEARABLE INJECTOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. WEARABLE INJECTOR MARKET SIZE, BY BODY WORN PATCH INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. WEARABLE INJECTOR MARKET SIZE, BY OFF BODY WORN PATCH INJECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. WEARABLE INJECTOR MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. WEARABLE INJECTOR MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. WEARABLE INJECTOR MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. WEARABLE INJECTOR MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. WEARABLE INJECTOR MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 15. WEARABLE INJECTOR MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. WEARABLE INJECTOR MARKET SIZE, BY HOME CARE SETTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. WEARABLE INJECTOR MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. WEARABLE INJECTOR MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. WEARABLE INJECTOR MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. WEARABLE INJECTOR MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. CANADA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. MEXICO WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES WEARABLE INJECTOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. CHINA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CHINA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. INDIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. JAPAN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. THAILAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA WEARABLE INJECTOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. DENMARK WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. EGYPT WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FINLAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. FRANCE WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. GERMANY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. ITALY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. ITALY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. NORWAY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. POLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. POLAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. QATAR WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. QATAR WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SPAIN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. TURKEY WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM WEARABLE INJECTOR MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 148. WEARABLE INJECTOR MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. WEARABLE INJECTOR MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. WEARABLE INJECTOR MARKET LICENSE & PRICING

Companies Mentioned

  • Amgen Inc.
  • BASF SE
  • Becton, Dickinson and Company
  • DCA Design International Ltd
  • E3D Elcam Drug Delivery Devices
  • Gerresheimer AG
  • Insulet Corporation
  • Johnson & Johnson Service Co., Inc.
  • Medtronic PLC
  • Neuma LLC
  • SCHOTT AG
  • SONCEBOZ SA
  • Stevanato Group S.p.A.
  • Valeritas, Inc.
  • West Pharmaceutical Services, Inc.

Methodology

Loading
LOADING...

Table Information